KD Pharma Group invests in Nutriceutical Holdings

Published: 5-Jun-2017

KD Pharma Group will become the largest shareholder in Nutriceutical Holdings with the option to acquire the entire company

Nutriceutical Holdings (NH), parent company of Physician Recommended Nutriceuticals (PRN) and Veterinarian Recommended Solutions (VRS), and KD Pharma Group have decided to join forces through a direct investment in Nutriceutical Holdings by KD Pharma Group.

“We believe we have found the ideal partner in KD. They are committed to growing the NH companies by providing us with supply chain certainty and superior Omega-3 manufacturing technology that can help us excel within a competitive Omega-3 landscape," said PRN CEO, Ken Krieg.

"We are pleased to have a capital partner that shares our vision for growing PRN and VRS.”

"We are extremely excited to be partnering with a fast-growing company that shares our passion for product excellence," says KD Pharma CEO, Oscar Groet. "The investment in NH gives KD growth opportunities in two rapidly growing markets for Omega 3, eye and animal health.”

About Nutriceutical Holdings

Physician Recommended Nutriceuticals is a leading producer of Omega-3 nutriceuticals. Developed by doctors and recommended by world-renowned medical thought leaders, PRN's products are supported by medical evidence and offer exceptional quality and purity. PRN is one of the fastest growing privately held companies and has appeared on the INC 5000 list for 4 years in a row. www.prnomegahealth.com

Veterinarian Recommended Solutions partners with veterinarians to distribute premier clinically-proven products that are only available through a veterinarian's recommendation. The company is guided by a group of veterinarian investors, advisors, researchers and board members that help drive growth plans and oversee new product development. www.vrshealth.com

About KD Pharma Group

The KD Pharma Group is the third largest Omega-3 producer in the world with 400 employees and 7 sites located in Norway, Germany and the US. The company concentrates nutriceutical and pharmaceutical oils and customised finished products for its customers in soft gel and bottled forms. The KD Pharma Group has the global reach, technology and vertical integration necessary to develop customised Omega-3 products with complete supply chain efficiency for our customers. www.KDPharmagroup.com

You may also like